A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1Since this study is only enrolling people by invitation who already received an A2 Bio gene therapy product, can you tell me whether I would even be eligible to participate based on my treatment history?
2. 2This trial is specifically tracking long-term safety after gene therapy — what kinds of delayed side effects or late-onset risks are researchers most concerned about watching for in studies like this, and how might that affect my ongoing monitoring plan?
3. 3What does participation in a long-term follow-up study like this actually involve day-to-day — how often would I need to come in for visits, what tests would be done, and how long would I be followed?
4. 4Since this is a follow-up safety study rather than a treatment trial, does enrolling change anything about the standard care or other treatment options I might pursue for my cancer going forward?
5. 5Given that the goal here is to collect long-term safety data on gene therapy I've already received, what information from this study could actually help inform decisions about my future care?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.